The commentary provided by Maase et al. [1] demonstrates how the novel algorithm [2] could be utilised by countries to evaluate disorders through expanded newborn screening programmes. We read with interest the detail provided about the Dutch evaluation method and appreciate the similarities described in their point-based scoring approach. We thank the authors for their comments.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Maase R., Jansen M.E., Heijnen M.-L., Dekkers E. Comment on Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20. Int. J. Neonatal Screen. 2023;9:7. doi: 10.3390/ijns9010007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Burlina A., Jones S.A., Chakrapani A., Church H.J., Heales S., Wu T.H.Y., Morton G., Roberts P., Sluys E.F., Cheillan D. A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes. Int. J. Neonatal Screen. 2022;8:25. doi: 10.3390/ijns8020025. [DOI] [PMC free article] [PubMed] [Google Scholar]